- Home
- GVA vs BHVN Comparison
GVA vs BHVN Comparison
Compare GVA & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVA
- BHVN
- Stock Information
- Founded
- GVA 1922
- BHVN 2013
- Country
- GVA United States
- BHVN United States
- Employees
- GVA N/A
- BHVN N/A
- Industry
- GVA Military/Government/Technical
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- GVA Industrials
- BHVN Health Care
- Exchange
- GVA Nasdaq
- BHVN Nasdaq
- Market Cap
- GVA 4.2B
- BHVN 3.6B
- IPO Year
- GVA 1990
- BHVN 2017
- Fundamental
- Price
- GVA $90.62
- BHVN $36.17
- Analyst Decision
- GVA Hold
- BHVN Strong Buy
- Analyst Count
- GVA 2
- BHVN 13
- Target Price
- GVA $67.00
- BHVN $63.00
- AVG Volume (30 Days)
- GVA 673.6K
- BHVN 1.1M
- Earning Date
- GVA 02-20-2025
- BHVN 11-12-2024
- Dividend Yield
- GVA 0.57%
- BHVN N/A
- EPS Growth
- GVA 144.49
- BHVN N/A
- EPS
- GVA 2.18
- BHVN N/A
- Revenue
- GVA $3,963,969,000.00
- BHVN N/A
- Revenue This Year
- GVA $14.59
- BHVN N/A
- Revenue Next Year
- GVA $6.86
- BHVN $197.10
- P/E Ratio
- GVA $41.66
- BHVN N/A
- Revenue Growth
- GVA 17.81
- BHVN N/A
- 52 Week Low
- GVA $43.92
- BHVN $26.80
- 52 Week High
- GVA $105.20
- BHVN $62.21
- Technical
- Relative Strength Index (RSI)
- GVA 35.08
- BHVN 33.02
- Support Level
- GVA $89.10
- BHVN $36.70
- Resistance Level
- GVA $93.75
- BHVN $42.13
- Average True Range (ATR)
- GVA 2.84
- BHVN 2.84
- MACD
- GVA -1.38
- BHVN -0.67
- Stochastic Oscillator
- GVA 3.85
- BHVN 13.18
About GVA Granite Construction Incorporated
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. It focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, with the remainder derived from its Materials segment.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.